Delivery Order SPE2DB20D2104-SPE2DB24FT76A
- Not listed
- This federal contract award is for the delivery of pharmaceutical products, primarily the medication Jardiance 10 mg tablets, to the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,124.56, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of pharmaceutical products, specifically Jardiance 10 mg tablets, to DLA Troop Support Medical. The $8,647.17 firm fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of December 22, 2023 and was awarded on December 21, 2023. There is no set-aside designation for this contract. Amerisourcebergen...
- This federal contract award is for the delivery of pharmaceutical products, including Jardiance 10 mg tablets, to the Defense Logistics Agency Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $25,959.78 and an ultimate completion date of February 23, 2024. The contract is a delivery order with a firm fixed price pricing type and was awarded on February 22,...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The $6,839.29 Firm Fixed Price Delivery Order contract was awarded by the Defense Logistics Agency (DLA) for the supply of Jardiance 10 mg tablets. The contract has an ultimate completion date of January 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is for the delivery of pharmaceutical products, primarily Jardiance 10 mg tablets, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,896.70, was awarded on July 18, 2022 and has a completion date of July 19, 2022. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of pharmaceutical products, specifically the medication Jardiance 10 mg tablets, to the Defense Logistics Agency (DLA). The contract, valued at $4,061.41, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 12, 2024, with a completion date of March 13, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award is for the delivery of pharmaceutical products, specifically the medication Jardiance 10 mg tablet, by Amerisourcebergen Drug Corp to the Defense Logistics Agency (DLA). The contract has a ceiling value of $18,695.84 and a period of performance through May 7, 2025. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Jardiance 10 mg tablets. The $6,911.09 firm-fixed-price delivery order contract has an ultimate completion date of January 28, 2025. The contract was not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is for the delivery of pharmaceutical products, specifically Jardiance 10 mg tablets, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $63,747.46, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is May 16, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is for the delivery of Jardiance 10 mg tablets over a 1-year period ending on May 3, 2023. The $16,696.69 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT76ADelivery Order
This federal contract award is for the delivery of pharmaceutical products, specifically Jardiance 10 mg tablets, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,017.88 and an ultimate completion date of April 23, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 4/22/24 |